Concise review: managing genotoxicity in the therapeutic modification of stem cells.
about
Genome-editing Technologies for Gene and Cell TherapyHematopoietic-stem-cell-based gene therapy for HIV diseaseGene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.The various aspects of genetic and epigenetic toxicology: testing methods and clinical applicationsGenomic discovery of potent chromatin insulators for human gene therapy.Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques.Normalization and improvement of CNS deficits in mice with Hurler syndrome after long-term peripheral delivery of BBB-targeted iduronidase.Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome.Genetic instability of modified stem cells - a first step towards malignant transformation?Somatic Cell Reprogramming into Cardiovascular Lineages.Evolving Gene Therapy in Primary Immunodeficiency.Clonal Dominance With Retroviral Vector Insertions Near the ANGPT1 and ANGPT2 Genes in a Human Xenotransplant Mouse Model.Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control.Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.Contribution of reactive oxygen species (ROS) to genotoxicity of nitrobenzene on V. faba.Getting the Most: Enhancing Efficacy by Promoting Erythropoiesis and Thrombopoiesis after Gene Therapy in Mice with Hurler Syndrome
P2860
Q26769662-BD37E8F0-ADC9-44E7-B505-8CE1B605BDA8Q27023434-D4B771AB-2AB1-48C3-8C64-A08CE76F17D8Q30364488-CFFE8375-E744-4292-B9E6-6C973C986F21Q33587018-AD8B7316-E185-4184-9ADE-67F6853B6CA3Q33716668-960AAC73-6E4D-4E13-B9DF-6A9A7B8E91B4Q34457712-70007996-DE3F-4C14-9E3A-2F6DEC4DF9B5Q34734779-13297B1D-88B0-4CDE-97CA-9319460B99CCQ35600316-8B29D826-6313-4170-A741-7E247F478D7AQ37599950-8D929133-807D-49DE-8E97-0E9AB2134D8DQ38106717-883A32BA-B8DA-4271-9C9A-65BEFC2943A9Q39203764-DE23BD89-C855-4174-AFCE-95ABC0C049CEQ39214064-9AD602EF-DBD1-495D-ACB1-1856985DD937Q42184255-775876E6-D782-4FF4-9C51-6E1C70ED5F81Q42553410-069B0092-6953-4740-8571-587E18D7CC9BQ43192156-7274DFA7-D903-46C9-BCE8-65F65A656F38Q46913195-D9ED1154-E27B-458E-8C2A-8671E2901A27Q58577240-7C7A7CAB-812F-4128-AE96-FF4257CC9FF4
P2860
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
@en
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
@nl
type
label
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
@en
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
@nl
prefLabel
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
@en
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
@en
P2093
Christopher Baum
Gudrun Göhring
Ute Modlich
P2860
P304
P356
10.1002/STEM.716
P577
2011-10-01T00:00:00Z